Sangamo Therapeutics Selects Successful Bidders Following Competitive Asset Auction

Click here to view

Additional information about the Chapter 11 reorganization and asset sales is available through Sangamo's noticing agent at https://www.veritaglobal.net/SangamoTherapeutics.

Presentation

Poster: Optimal Drug Product Presentation and Container Closure Selection for AAV-Based Genomic Medicines

Download PDF